AzTrials
AzTrials

MyopiaNCT05336799

Prevalence and Environmental Factors for Myopia Among Chinese School-aged Children and Adolescent in Tianjin

An observational study of Myopia and Refractive Errors, run by Tianjin Eye Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The high prevalence of myopia has become a global public health problem. The study amied to investigate the prevalence and progression of myopia associated with social environmental factors in Tianjin, a Chinese megacity in north China. Read more about this study

Who is it for?
Ages 6 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Myopia, Refractive Errors
How many people
500,000 participants
Where
1 siteChina
Study dates
1 Mar 2021to 31 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: All school-aged children and adolescents completed the vision screening in the included school.

Who may be able to join

  • aged 6 to 18 years
  • no ocular diseases and systemic diseases
  • consent to undergo an eye examination

Who cannot join

  • schoolchildren unwilling to participate

Trial locations and contacts

1 site in 1 country.

xiaoyan yang, director contact

+8627306525

yanzitjsykyy@163.com

yan wang, director contact

+862227313336

wangyan7143@vip.sina.com

China1 site, 1 recruiting
  • Tianjin Eye Hospital

    Tianjin, Tianjin Municipality

    yan wang, director, +862227313336, wangyan7143@vip.sina.com

    Recruiting

Other trials in China

About this study

The high prevalence of myopia has become a global public health problem. The study amied to investigate the prevalence and progression of myopia associated with social environmental factors in Tianjin, a Chinese megacity in north China.

Read the detailed description

The high prevalence of myopia has become a global public health problem, especially in East and South Asian countries. It's still not clear for the prevalence and progression of myopia associated with social environmental factors. Thus, the investigators will conducted a long-term observational study to the effect of the socioeconomics, medical resources and school-related environmental parameters and others on the prevalence and progression of myopia among Chinese school-aged children and adolescent.

Keywords
Myopia, Socioeconomics
Medical subject headings
Myopia, Refractive Errors

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of myopia

    Myopia is defined as any eye's SER (sphere + 1/2 cylinder) of at least -0.5 diopters (D).

    Measured: up to 3years

Secondary outcomes (2)
  1. Changes in prevalence of myopia

    Myopia is defined as any eye's SER (sphere + 1/2 cylinder) of at least -0.5 diopters (D).

    Measured: up to 3years

  2. Changes of Spherical equivalent

    Changes of Spherical equivalent

    Measured: changes from baseline at 36months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2022
  2. Study start1 Mar 2021
  3. Primary completion1 Dec 2022 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05336799
Sponsor's protocol ID
Tianjin Myopia Study
Status last verified
Nov 2022
First submitted
8 Apr 2022
Last updated
29 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, Rose KA. The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res. 2018 Jan;62:134-149. doi: 10.1016/j.preteyeres.2017.09.004. Epub 2017 Sep 23.

    PubMed 28951126
  • Guo Y, Liu LJ, Xu L, Lv YY, Tang P, Feng Y, Meng M, Jonas JB. Outdoor activity and myopia among primary students in rural and urban regions of Beijing. Ophthalmology. 2013 Feb;120(2):277-83. doi: 10.1016/j.ophtha.2012.07.086. Epub 2012 Oct 23.

    PubMed 23098368
  • Tenovuo J, Mielityinen H, Paunio K. The effect of dental plaque grown in the presence of xylitol or sucrose on bone resorption in vitro. Pharmacol Ther Dent. 1981;6(1-2):35-43.

    PubMed 6941318

Questions about this trial

What is this clinical trial studying?

An observational study of Myopia and Refractive Errors, run by Tianjin Eye Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact xiaoyan yang, director (+8627306525, yanzitjsykyy@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of myopia (time frame: up to 3years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05336799, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in